Group 1 - The core stock price of Chenxin Pharmaceutical (603367) closed at 14.71 yuan on June 13, 2025, down 1.21% from the previous week [1] - The stock reached a nearly one-year high of 16.13 yuan on June 10, 2025, with a lowest price of 14.61 yuan on June 13, 2025 [1] - The current total market capitalization of Chenxin Pharmaceutical is 6.66 billion yuan, ranking 77th out of 150 in the chemical pharmaceutical sector and 2295th out of 5150 in the A-share market [1] Group 2 - Shareholder Han Yanzhen, holding 31,977,829 shares (7.06% of total shares), released 16,510,000 shares from pledge, accounting for 3.65% of total shares [1] - After the release, Han Yanzhen has a total of 15,220,000 shares pledged, which is 3.36% of total shares and 47.60% of his holdings [1] - There are no subsequent pledge plans for the released shares [1] Group 3 - Chenxin Pharmaceutical announced a cash dividend of 0.22 yuan per share, with the A-share registration date set for June 18, 2025, and the dividend payment date on June 19, 2025 [2] - The total cash dividend distribution amounts to approximately 99.61 million yuan based on the total share capital of 452,754,129 shares [2] - Individual shareholders holding shares for over one year are exempt from personal income tax on dividend income, while those holding for less than one year will not have tax withheld at the time of distribution [2]
每周股票复盘:辰欣药业(603367)股东解除质押及年度权益分派实施